Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives
Chemical Biology & Drug Design · 2026
DOI: 10.1111/cbdd.70387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Zeynep Zişan Demirci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Institute of Graduate Education, Anadolu University, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Hydrazones, Antineoplastic Agents, Thiazoles. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The anticancer efficacy of 4‐aryl‐2‐hydrazinothiazole derivatives, which combine a thiazole known for its wide range of medicinal applications and a hydrazide/hydrazone structure known for its unique biological properties, has been determined in numerous studies. In this study, novel 2‐[4‐[(2‐(4‐substituted thiazol‐2‐yl)hydrazono)methyl]phenoxy]acetic acid derivatives ( 2a–l ) were synthesized and evaluated for their anticancer activity in MCF‐7 breast cancer, A549 lung cancer, and L929 normal cell lines using cytotoxicity, apoptosis, and caspase‐3 activation assays. The compounds were found to exhibit high cytotoxicity, particularly showing more selective and high‐potential antiproliferative activity on the MCF‐7 cell line. In apoptosis studies, compounds 2c , 2d , and 2h caused programmed cell death in MCF‐7 cells exceeding 24%, close to cisplatin. Among these compounds, the derivative 2c containing 4‐methoxyphenyl caused caspase‐3 activation at a level similar to cisplatin. To conduct in silico studies of the compounds, molecular docking studies with the (4QTX) caspase‐3 enzyme, molecular dynamics simulation for three compounds ( 2d , 2g and 2l ), and Density Functional Theory (DFT) studies were performed. These studies have shown that the carboxylate groups in the compounds form strong and stable interactions with Arg64 and Arg207.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Institute of Graduate Education, Anadolu University, Eskişehir, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, İstanbul, Turkey.
- Department of Biohemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
ORCID-Profile: Erol Akgün, Gülşen Akalın Çiftçi, Leyla Yurttaş
Zitieren
APA
Demirci, Z. Z., Akgün, E., Çiftçi, G. A., & Yurttaş, L. (2026). Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70387
Vancouver
Demirci ZZ, Akgün E, Çiftçi GA, Yurttaş L. Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70387
BibTeX
@article{Demirci2026,
author = {Demirci, Zeynep Zişan and Akgün, Erol and Çiftçi, Gülşen Akalın and Yurttaş, Leyla},
title = {Investigation of the In Vitro and In Silico Anticancer Potential of Novel 4‐Arylthiazole‐Hydrazone Derivatives},
journal = {Chemical Biology & Drug Design},
year = {2026},
doi = {10.1111/cbdd.70387}
}
EUVIMED